Daniela retweeted
Boost Your Pharma Innovation with an Aussie Advantage!
At Ab Initio Pharma, we're more than just a CDMO—we're Australia's trusted partner for innovative pharmaceutical development, specialising in complex dosage forms.
Daniela retweeted
Drop by booth 210 to learn how Ab Initio can help you develop clinic ready OINDPs at drug delivery to the lungs 2024 #GMP #formulation #DDL2024
Daniela retweeted
Ab initios CSO, YY talks about advanced nasal drug delivery of RNA using Tetatherix matrix #ddl2024
Daniela retweeted
Join Ab Initio at the Targeted Drug Delivery Innovations showcase next week, hosted by the
BioNSW and BioMelbourne Network, to learn about how we are innovating in complex dosage form design and manufacture. ab-initio-pharma.com/news/20…
#BioNSW #GMP #CDMO @aptar
Daniela retweeted
Great to be at the Inaugural NSW Drug Discovery Forum. An exciting day of innovation ahead @AnneCONeill opens the proceedings @MedResearchNSW @Sydney_DDI @duncan_macinnis @MTPConnect_AUS
Daniela retweeted
With only a week to go to AusBio2024, don't forget to book a time to meet with our team to discus all your CDMO needs #GMP #ClinicalTrials #MenInOrange
ab-initio-pharma.com/news/20…
Daniela retweeted
Meet Lin: Leading Complex Dosage Form GMP Manufacturing at Our CDMO
linkedin.com/feed/update/urn…
#InnovationInAction #PharmaceuticalExcellence #CDMO
Daniela retweeted

ALT Men in Orange is a high-stakes industrial thriller set in the world of pharmaceutical manufacturing, where quality, safety, and ethics are paramount—and where cutting corners can have deadly consequences. Explore the hidden world of Good Manufacturing Practice (GMP), regulatory compliance, and the dangerous forces threatening the integrity of therapeutic drug production for clinical trials. Register to meet with the Men in Orange at AusBio 2024
Daniela retweeted
Discover Ab Initio's Mission: Driving Innovation in Therapeutics – An Exclusive Interview at ARCS Australia 2024
youtu.be/ZwFclAqpjz0?si=xFM9…
Daniela retweeted
Developing next-gen MDIs. Come and talk to the OzUk team about fast tracking your new product to market. Our rapid bench to pivot scale novel propellant development services will give you the upper hand. Exploring the Future of Inhalation Drug Delivery Conference 2024, Parma IT
Daniela retweeted
Meet with the Ab Initio team to discuss our CDMO GMP capabilities for both small molecule and biological OINDP development. Exploring the Future of Inhalation Drug Delivery Conference 2024, Parma Italy.
Daniela retweeted
Ab Initio is proud to launch its ABVANCE Commercialisation Award at the 2024 NSW Drug Discovery Form
ab-initio-pharma.com/news/20…
Daniela retweeted
Advanced Physicochemical characterisation tools for next generation MDI formulation published in Inhalation Magazine.
ab-initio-pharma.com/resourc…
Daniela retweeted
And Action! Ab Initio talks to @THTpodcast
Daniela retweeted
Ab Initio is #ARCS2024. Come and chat to the team about all your CDMO needs!
Daniela retweeted
Prof Daniela Traini presents some excellent work from the @AbinitioPharma Tetratherix partnership #RDD2024
Daniela retweeted
Dr Will Glover talks about responsibilities and risks to sponsors running clinical trials with investigational medicinal products. #RACI #GMP @RACInational code of GMP Seminar series
Daniela retweeted
Do you know what is in your trial medicine? Read Ab Initio's opinion piece on GMP vs compounding in early phase clinical trials.
ab-initio-pharma.com/news/20…












